Researchers are exploring the use of nanoparticles to target and degrade specific proteins, a technology that may lead to new therapeutics. This approach is being investigated for potential applications in various diseases, including cancer, neurodegenerative disorders, and hematologic malignancies. The development of targeted protein degradation technologies, including nanoparticle-mediated and lysosome-targeting strategies, is an emerging area of research in the field of drug discovery.